CB Therapeutics
About:
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
Website: https://cbthera.com/
Twitter/X: cbtherapeutics
Top Investors: Y Combinator, Pioneer Fund, EvoNexus, Mystic Ventures, re.Mind Capital
Description:
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar. CB Therapeutics produces pure cannabinoids like CBD and THC using yeast and sugar. No plants involved.
Total Funding Amount:
$7.62M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
La Jolla, California, United States
Founded Date:
2015-05-20
Founders:
Jacob Vogan, Sher Ali Butt
Number of Employees:
11-50
Last Funding Date:
2023-01-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai